CE0031 is expressed in Escherichia coli, a widely used host for recombinant protein production. Key steps include:
Expression System: Optimized using E. coli strains (e.g., BL21 derivatives) to balance membrane protein synthesis and cell viability .
Purification: Affinity chromatography via His tag, yielding >90% purity as verified by SDS-PAGE .
Form: Lyophilized powder in Tris/PBS-based buffer with 6% trehalose (pH 8.0) .
CE0031 is annotated as a cell division protein (crgA), homologous to proteins in Streptomyces coelicolor (SCO3854) and Mycobacterium tuberculosis (Rv0011c) . These homologs regulate septation during bacterial cell division, though direct functional data for CE0031 remains limited.
Structural Studies: Used in crystallography or cryo-EM to resolve membrane protein architectures.
Antigen Production: Serves as an immunogen for antibody development .
Protein Interaction Assays: Identified as a candidate for studying bacterial cell division machinery .
Involved in cell division.
KEGG: cef:CE0031
STRING: 196164.HMPREF0290_2698
Recombinant UPF0233 membrane protein CE0031 (UniProt ID: Q8FUI7) is a small membrane protein from Corynebacterium efficiens that spans 90 amino acids. It's also known as Cell division protein CrgA (gene name: crgA) . The protein is typically produced with an N-terminal His tag to facilitate purification when expressed in E. coli systems. While the "UPF" designation indicates it belongs to an uncharacterized protein family, research suggests its involvement in cell division processes in Corynebacterium species. The protein likely functions within the membrane environment to facilitate cellular division, though specific molecular mechanisms remain under investigation.
For optimal expression:
Use the BL21ΔABCF strain, particularly for small outer membrane β-barrel proteins
Grow cultures at 30°C rather than 37°C (the quadruple mutant grows better at lower temperatures)
Use appropriate induction parameters based on your expression vector system
Include proper tags (His-tag is common) to facilitate downstream purification
Note that growth behavior will differ from standard BL21(DE3) strains, with slower growth rates but potentially higher final protein yields for membrane proteins .
Proper reconstitution of UPF0233 membrane protein CE0031 is critical for maintaining structural integrity and function. Follow this methodological approach:
Centrifuge the lyophilized protein vial briefly to collect all material at the bottom
Reconstitute in deionized sterile water to a concentration of 0.1-1.0 mg/mL
Add glycerol to a final concentration of 50% (range of 5-50% is acceptable) to prevent freeze-thaw damage
Aliquot into small volumes to minimize freeze-thaw cycles
Store reconstituted protein at -20°C/-80°C for long-term storage, or at 4°C for up to one week for active experiments
The addition of glycerol is particularly important as membrane proteins are susceptible to denaturation during freeze-thaw cycles. For experiments requiring the native conformation, consider reconstitution into appropriate lipid bilayers or detergent micelles that mimic the membrane environment.
UPF0233 membrane protein CE0031 requires specific storage conditions to maintain stability and activity:
| Storage Phase | Recommended Condition | Duration | Notes |
|---|---|---|---|
| Lyophilized form | -20°C to -80°C | Long-term | Original sealed container |
| Reconstituted | -20°C to -80°C | Long-term | In aliquots with 50% glycerol |
| Working solution | 4°C | Up to one week | For active experiments |
Repeated freeze-thaw cycles significantly reduce protein quality and should be strictly avoided . For optimal results, immediately aliquot reconstituted protein into single-use volumes. The storage buffer composition (Tris/PBS-based buffer with 6% Trehalose, pH 8.0) helps maintain protein stability, but additional stabilizers like glycerol are required for freeze storage.
When investigating UPF0233 membrane protein function, consider implementing these research design approaches:
Comparative expression analysis: Express the protein in both standard BL21(DE3) and optimized BL21ΔABCF strains to assess expression efficiency and protein quality via Western blotting and activity assays
Structured time-series experimentation: Implement interrupted time series (ITS) designs to evaluate protein function under varying conditions, measuring outcomes at multiple timepoints before and after interventions
Stepped-wedge design: When testing multiple conditions or mutations, use a staggered implementation approach where all experimental units eventually receive the intervention but in a randomized sequence
Membrane environment studies: Compare protein behavior in different membrane mimetics (detergent micelles, nanodiscs, liposomes) to identify optimal conditions for functional studies
Biophysical measurements: Utilize the unique attributes of BL21ΔABCF strains that facilitate labeling experiments in the native membrane environment for direct biophysical measurements
For rigorous implementation science approaches, combine these methods with appropriate controls and replication to ensure reproducibility and statistical power .
Purification of UPF0233 membrane protein CE0031 requires specialized approaches due to its membrane-embedded nature. Researchers should follow this advanced purification workflow:
Expression optimization:
Cell lysis and membrane isolation:
Use gentle lysis methods (osmotic shock or enzymatic methods)
Separate membrane fractions via ultracentrifugation (100,000×g for 1 hour)
Wash membrane pellets to remove peripheral proteins
Detergent solubilization:
Screen multiple detergents (e.g., DDM, LDAO, OG) for optimal solubilization
Maintain solubilization temperature at 4°C
Use gentle rotation rather than harsh agitation
Affinity chromatography:
Utilize the N-terminal His-tag with Ni-NTA resin
Include detergent in all buffers at concentrations above CMC
Implement step gradients for washing and elution
Quality assessment:
This methodological approach accounts for the challenges specific to membrane proteins and leverages the His-tag design of the recombinant construct .
Structural characterization of UPF0233 membrane protein CE0031 presents several methodological challenges that researchers must address systematically:
Protein stability considerations:
Crystallization barriers:
Membrane proteins typically have lower crystallization success rates
Detergent micelles can interfere with crystal contacts
The small size may provide insufficient crystal contacts
NMR spectroscopy approaches:
Isotopic labeling requires optimized minimal media conditions in the expression system
Detergent selection critically impacts spectral quality
The multiple transmembrane regions can lead to signal overlap
Cryo-EM considerations:
The small size (90 residues, ~10 kDa) falls below typical size limits for single-particle cryo-EM
Strategies like antibody labeling or fusion partners may be necessary
Specialized grid preparation techniques for membrane proteins are required
To overcome these challenges, researchers should consider:
Using the optimized BL21ΔABCF strain for improved expression quality
Applying lipid cubic phase or bicelle crystallization methods
Implementing advanced labeling strategies for NMR spectroscopy
Exploring newer detergent-free systems like styrene maleic acid lipid particles (SMALPs)
Site-directed mutagenesis represents a powerful approach for investigating UPF0233 membrane protein CE0031 function. Implement the following methodological workflow:
Target identification:
Mutagenesis strategy:
Expression comparison:
Functional assessment:
Develop membrane localization assays
Assess oligomerization state changes via crosslinking
Measure effects on cell division if expressing in Corynebacterium model systems
Structural impact analysis:
Use circular dichroism to assess secondary structure perturbations
Apply limited proteolysis to identify structural changes
Consider thermal stability assays to quantify folding impacts
This systematic approach enables researchers to correlate specific amino acid positions with functional outcomes, thereby elucidating structure-function relationships for this membrane protein.
Researchers frequently encounter several challenges when expressing UPF0233 membrane protein CE0031. Here are methodological solutions to these common issues:
Low expression levels:
Protein aggregation:
Poor solubilization:
Screen multiple detergent types and concentrations
Implement step-wise solubilization protocols starting with milder detergents
Consider native nanodiscs or SMALPs for extraction without conventional detergents
Degradation during purification:
Add protease inhibitor cocktails throughout all purification steps
Maintain samples at 4°C throughout processing
Minimize time between cell harvest and protein purification
Low protein purity:
These solutions address the specific challenges associated with this membrane protein while leveraging the advantages of optimized expression systems .
Verifying proper folding and activity of UPF0233 membrane protein CE0031 requires multiple complementary approaches:
Biochemical characterization:
Size exclusion chromatography to confirm monomeric state or defined oligomers
Circular dichroism spectroscopy to assess secondary structure content expected of membrane proteins
Thermal stability assays to determine melting temperature and stability parameters
Membrane integration assessment:
Membrane fractionation followed by Western blotting to confirm localization
Protease protection assays to verify topology within membranes
Fluorescent labeling and microscopy to visualize membrane localization
Functional verification:
For CrgA/CE0031's putative role in cell division, assess complementation in knockout models
Analyze protein-protein interactions with known cell division proteins
Measure effects on cell morphology when overexpressed
Structural integrity checks:
Limited proteolysis to verify compact folding (properly folded proteins show resistance to digestion)
Tryptophan fluorescence to assess tertiary structure environment
Antibody recognition of conformational epitopes
Activity assays:
As this is an UPF (uncharacterized protein family), design activity assays based on bioinformatic predictions
Consider lipid binding assays to assess membrane interaction properties
Measure oligomerization dynamics using FRET-based approaches
These methodological approaches provide a comprehensive assessment of protein quality beyond simple expression and purification verification .
Studying membrane integration of UPF0233 CE0031 requires specialized analytical methods that provide insights into protein-membrane interactions:
Biophysical membrane association analyses:
Structural membrane topology determination:
Cysteine scanning mutagenesis combined with accessibility assays
Hydrogen/deuterium exchange mass spectrometry to identify membrane-protected regions
Electron paramagnetic resonance spectroscopy with site-directed spin labeling
Advanced microscopy techniques:
Super-resolution microscopy of fluorescently labeled protein to visualize membrane distribution
Atomic force microscopy of reconstituted proteoliposomes to visualize topography
Cryo-electron microscopy of membrane-embedded protein
Computational approaches:
Biochemical membrane integration assays:
Alkaline extraction to differentiate peripheral from integral membrane proteins
Protease protection assays to map exposed versus membrane-embedded domains
Crosslinking studies to identify adjacent membrane proteins in native environments
These methodological approaches provide complementary data about how CE0031 integrates into and functions within biological membranes, leveraging both conventional techniques and advanced technologies .
Several promising research directions could advance our understanding of UPF0233 membrane protein CE0031:
Structural biology advancements:
Functional characterization:
Systematic interactome mapping in Corynebacterium to identify binding partners
Gene knockout/complementation studies to definitively establish physiological roles
Evolution of CrgA/CE0031 across bacterial species to understand conserved functions
Methodological innovations:
Development of cell-free expression systems optimized for this specific membrane protein
Application of non-canonical amino acid incorporation for specialized biophysical studies
Machine learning approaches to predict functional sites based on sequence conservation
Therapeutic potential exploration:
Assessment of CE0031 as a potential antibiotic target in pathogenic Corynebacterium species
Development of specific inhibitors if essential functions are confirmed
Exploration of immunological recognition in host-pathogen interactions
Biotechnological applications:
Engineering CE0031 as a potential membrane-targeting module for synthetic biology
Development of CE0031-based biosensors for detecting membrane perturbations
Exploration as a model system for membrane protein folding studies